{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:11:10Z","timestamp":1791835870137,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73175-4","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T05:02:31Z","timestamp":1727672551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Surface protein distribution in Group B Streptococcus isolates from South Africa and identifying vaccine targets through in silico analysis"],"prefix":"10.1038","volume":"14","author":[{"given":"Vicky","family":"Gent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindiswa","family":"Lukhele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyaad","family":"Dangor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Hosken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"73175_CR1","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1093\/cid\/cix664","volume":"65","author":"AC Seale","year":"2017","unstructured":"Seale, A. C. et al. Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin. Infect. Dis.65, S200\u2013S219 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"73175_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(11)61651-6","volume":"379","author":"KM Edmond","year":"2012","unstructured":"Edmond, K. M. et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet379, 547\u2013556 (2012).","journal-title":"Lancet"},{"key":"73175_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.15643","author":"M Mynarek","year":"2023","unstructured":"Mynarek, M. et al. Mortality and neurodevelopmental outcome after invasive group B streptococcal infection in infants. Dev. Med. Child Neurolhttps:\/\/doi.org\/10.1111\/dmcn.15643 (2023).","journal-title":"Dev. Med. Child Neurol"},{"key":"73175_CR4","doi-asserted-by":"crossref","unstructured":"Dangor, Z., Seale, A. C., Baba, V. & Kwatra, G. Early-onset group B streptococcal disease in African countries and maternal vaccination strategies. Front. Public Health11 (2023).","DOI":"10.3389\/fpubh.2023.1214844"},{"key":"73175_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clp.2014.10.004","volume":"42","author":"L Ku","year":"2015","unstructured":"Ku, L., Boggess, K. & Cohen-Wolkowiez, M. Bacterial meningitis in the infant. Clin. Perinatol.42, 29\u201345 (2015).","journal-title":"Clin. Perinatol."},{"key":"73175_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/jpids\/piv067","volume":"5","author":"J Pintye","year":"2016","unstructured":"Pintye, J., Saltzman, B., Wolf, E. & Crowell, C. S. Risk factors for late-onset group B streptococcal disease before and after implementation of universal screening and intrapartum antibiotic prophylaxis. J. Pediatr. Infect. Dis. Soc.5, 431\u2013438 (2016).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"73175_CR7","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ejogrb.2020.06.024","volume":"252","author":"PJ Steer","year":"2020","unstructured":"Steer, P. J., Bedford, A., Kochhar, S., Cox, P. & Plumb, J. Group B streptococcal disease in the mother and newborn\u2014A review. Eur. J. Obstet. Gynecol. Reprod. Biol.252, 526\u2013533 (2020).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"73175_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123014","volume":"10","author":"Z Dangor","year":"2015","unstructured":"Dangor, Z. et al. Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLoS One10, e0123014 (2015).","journal-title":"PLoS One"},{"key":"73175_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101358","volume":"47","author":"P Paul","year":"2022","unstructured":"Paul, P. et al. Neurodevelopmental and growth outcomes after invasive Group B Streptococcus in early infancy: A multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and Argentina. eClinicalMedicine47, 101358 (2022).","journal-title":"eClinicalMedicine"},{"key":"73175_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0123014","volume":"10","author":"Z Dangor","year":"2015","unstructured":"Dangor, Z. et al. Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLoS One10, 1\u201313 (2015).","journal-title":"PLoS One"},{"key":"73175_CR11","unstructured":"Stevens, D. & Kaplan, E. Molecular pathogenesis of Group B streptococcal disease in newborns. in Streptococcal Infections: Clinical aspects, Microbiology and Molecular pathogenesis, vol. 180 (Oxford University Press, 2000)."},{"key":"73175_CR12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/ciz360","volume":"70","author":"Z Dangor","year":"2020","unstructured":"Dangor, Z. et al. The association between breast milk group B streptococcal capsular antibody levels and late-onset disease in young infants. Clin. Infect. Dis.70, 1110\u20131114 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"73175_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2018.00437","volume":"9","author":"S Shabayek","year":"2018","unstructured":"Shabayek, S. & Spellerberg, B. Group B streptococcal colonization, molecular characteristics, and epidemiology. Front. Microbiol.9, 1\u201314 (2018).","journal-title":"Front. Microbiol."},{"key":"73175_CR14","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1093\/cid\/cix656","volume":"65","author":"L Madrid","year":"2017","unstructured":"Madrid, L. et al. Infant Group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin. Infect. Dis.65, S160\u2013S172. https:\/\/doi.org\/10.1093\/cid\/cix656 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"73175_CR15","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1016\/j.vaccine.2019.07.012","volume":"37","author":"AC Seale","year":"2019","unstructured":"Seale, A. C. et al. Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions. Vaccine37, 4877\u20134885. https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.012 (2019).","journal-title":"Vaccine"},{"key":"73175_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/2051013615579869","volume":"3","author":"A Nuccitelli","year":"2015","unstructured":"Nuccitelli, A., Rinaudo, C. D. & Maione, D. Group B Streptococcus vaccine: state of the art. Ther. Adv. Vaccines3, 76\u201390 (2015).","journal-title":"Ther. Adv. Vaccines"},{"key":"73175_CR17","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2147\/IDR.S203454","volume":"13","author":"C Carreras-Abad","year":"2020","unstructured":"Carreras-Abad, C., Ramkhelawon, L., Heath, P. T. & Doare, K. L. A vaccine against group b streptococcus: Recent advances. Infect. Drug Resist.13, 1263\u20131272. https:\/\/doi.org\/10.2147\/IDR.S203454 (2020).","journal-title":"Infect. Drug Resist."},{"key":"73175_CR18","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1016\/j.vaccine.2017.02.025","volume":"35","author":"SA Madhi","year":"2017","unstructured":"Madhi, S. A. & Dangor, Z. Prospects for preventing infant invasive GBS disease through maternal vaccination. Vaccine35, 4457\u20134460 (2017).","journal-title":"Vaccine"},{"key":"73175_CR19","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/infdis\/jis605","volume":"206","author":"S Bellais","year":"2012","unstructured":"Bellais, S. et al. Capsular switching in group B streptococcus CC17 hypervirulent clone: A future challenge for polysaccharide vaccine development. J. Infect. Dis. 206, 1745\u20131752 (2012).","journal-title":"J. Infect. Dis."},{"key":"73175_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1098\/rsif.2007.0236","volume":"5","author":"M Martcheva","year":"2008","unstructured":"Martcheva, M., Bolker, B. M. & Holt, R. D. Vaccine-induced pathogen strain replacement: What are the mechanisms?. J. R. Soc. Interface 5, 3\u201313 (2008).","journal-title":"J. R. Soc. Interface"},{"key":"73175_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1128\/CMR.18.1.102-127.2005","volume":"18","author":"G Lindahl","year":"2005","unstructured":"Lindahl, G., St\u00e5lhammar-Carlemalm, M. & Areschoug, T. Surface proteins of Streptococcusagalactiae and related proteins in other bacterial pathogens. Clin. Microbiol. Rev. 18, 102\u2013127. https:\/\/doi.org\/10.1128\/CMR.18.1.102-127.2005 (2005).","journal-title":"Clin. Microbiol. Rev."},{"key":"73175_CR22","doi-asserted-by":"crossref","unstructured":"Paoletti, L. C. & Kasper, D. L. Surface structures of group B Streptococcus important in human immunity. Microbiol. Spectr. 7 (2019).","DOI":"10.1128\/microbiolspec.GPP3-0001-2017"},{"key":"73175_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00437","author":"S Shabayek","year":"2018","unstructured":"Shabayek, S. & Spellerberg, B. Group B streptococcal colonization, molecular characteristics, and epidemiology. Front. Microbiol.https:\/\/doi.org\/10.3389\/fmicb.2018.00437 (2018).","journal-title":"Front. Microbiol."},{"key":"73175_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7010009","author":"T Lagousi","year":"2019","unstructured":"Lagousi, T., Basdeki, P., Routsias, J. & Spoulou, V. Novel protein-based pneumococcal vaccines: Assessing the use of distinct protein fragments instead of full-length proteins as vaccine antigens. Vaccineshttps:\/\/doi.org\/10.3390\/vaccines7010009 (2019).","journal-title":"Vaccines"},{"key":"73175_CR25","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3389\/fimmu.2020.01920","volume":"11","author":"T Clements","year":"2020","unstructured":"Clements, T. et al. Update on transplacental transfer of IgG subclasses: impact of maternal and fetal factors. Front. Immunol 11, 1920 (2020).","journal-title":"Front. Immunol"},{"key":"73175_CR26","doi-asserted-by":"crossref","unstructured":"Chong, L. C. & Khan, A. M. Vaccine target discovery. in Encyclopedia of Bioinformatics and Computational Biology: ABC of Bioinformatics vols. 1\u20133 241\u2013251 (Elsevier, 2018).","DOI":"10.1016\/B978-0-12-809633-8.20100-3"},{"key":"73175_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79645-9","volume":"10","author":"H Can","year":"2020","unstructured":"Can, H. et al. In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19. Sci. Rep. 10, 22387 (2020).","journal-title":"Sci. Rep."},{"key":"73175_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femspd\/ftx033","volume":"75","author":"M Christodoulides","year":"2017","unstructured":"Christodoulides, M. & Heckels, J. Novel approaches to Neisseriameningitidis vaccine design. Pathog. Dis. 75, 1\u201316 (2017).","journal-title":"Pathog. Dis."},{"key":"73175_CR29","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.1128\/IAI.68.10.5610-5618.2000","volume":"68","author":"BR Brodeur","year":"2000","unstructured":"Brodeur, B. R. et al. Identification of Group B streptococcal sip protein, which elicits cross-protective immunity. Infect. Immun. 68, 5610\u20135618 (2000).","journal-title":"Infect. Immun."},{"key":"73175_CR30","unstructured":"Maione, D. et al. Identification of a universal group B streptococcus vaccine by multiple genome screen. www.sciencemag.org\/cgi\/content\/full\/309\/5731\/148\/DC1"},{"key":"73175_CR31","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/cid\/ciaa151","volume":"72","author":"L McGee","year":"2021","unstructured":"McGee, L. et al. Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive group B streptococci within the United States, 2015\u20132017. Clin. Infect. Dis. 72, 1004\u20131013 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"73175_CR32","first-page":"194","volume":"4","author":"AM Kanampalliwar","year":"2013","unstructured":"Kanampalliwar, A. M., Soni, R., Girdhar, A. & Tiwari, A. Reverse vaccinology: Basics and applications. J. Vaccines Vaccin. 4, 194 (2013).","journal-title":"J. Vaccines Vaccin."},{"key":"73175_CR33","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","volume":"33","author":"A Sette","year":"2010","unstructured":"Sette, A. & Rappuoli, R. Reverse vaccinology: Developing vaccines in the era of genomics. Immunity 33, 530\u2013541. https:\/\/doi.org\/10.1016\/j.immuni.2010.09.017 (2010).","journal-title":"Immunity"},{"key":"73175_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.00751","volume":"10","author":"V Masignani","year":"2019","unstructured":"Masignani, V., Pizza, M. & Moxon, E. R. The development of a vaccine against Meningococcus B using reverse vaccinology. Front. Immunol. 10, 1\u201314. https:\/\/doi.org\/10.3389\/fimmu.2019.00751 (2019).","journal-title":"Front. Immunol."},{"key":"73175_CR35","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1007\/s12010-014-0749-x","volume":"172","author":"S Talukdar","year":"2014","unstructured":"Talukdar, S., Zutshi, S., Prashanth, K. S., Saikia, K. K. & Kumar, P. Identification of potential vaccine candidates against Streptococcuspneumoniae by reverse vaccinology approach. Appl. Biochem. Biotechnol. 172, 3026\u20133041 (2014).","journal-title":"Appl. Biochem. Biotechnol."},{"key":"73175_CR36","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3390\/vaccines9060669","volume":"9","author":"MA Soltan","year":"2021","unstructured":"Soltan, M. A. et al. In silico prediction of a multitope vaccine against Moraxellacatarrhalis: Reverse vaccinology and immunoinformatics. Vaccines (Basel) 9, 669 (2021).","journal-title":"Vaccines (Basel)"},{"key":"73175_CR37","first-page":"655","volume":"18","author":"K Mehdinejadiani","year":"2020","unstructured":"Mehdinejadiani, K. et al. In silico design and evaluation of Acinetobacterbaumannii outer membrane protein A (OmpA) antigenic peptides as vaccine candidate in immunized mice. Iran. J. Allergy Asthma Immunol. 18, 655\u2013663 (2020).","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"73175_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nbt1179","volume":"24","author":"MJ Rodr\u00edguez-Ortega","year":"2006","unstructured":"Rodr\u00edguez-Ortega, M. J. et al. Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat. Biotechnol. 24, 191\u2013197 (2006).","journal-title":"Nat. Biotechnol."},{"key":"73175_CR39","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1128\/IAI.73.3.1671-1683.2005","volume":"73","author":"R Seepersaud","year":"2005","unstructured":"Seepersaud, R. et al. Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity. Infect. Immun. 73, 1671\u20131683 (2005).","journal-title":"Infect. Immun."},{"key":"73175_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jinf.2021.04.003","volume":"83","author":"M Meehan","year":"2021","unstructured":"Meehan, M. et al. Genomic epidemiology of group B streptococci spanning 10 years in an Irish maternity hospital, 2008\u20132017. J. Infect. 83, 37\u201345 (2021).","journal-title":"J. Infect."},{"key":"73175_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017861","volume":"6","author":"M Madzivhandila","year":"2011","unstructured":"Madzivhandila, M. et al. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLoS One 6, e17861 (2011).","journal-title":"PLoS One"},{"key":"73175_CR42","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1093\/cid\/cix655","volume":"65","author":"NJ Russell","year":"2017","unstructured":"Russell, N. J. et al. Risk of early-onset neonatal group B streptococcal disease with maternal colonization worldwide: systematic review and meta-analyses. Clin. Infect. Dis. 65, S152\u2013S159 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"73175_CR43","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1128\/JCM.05488-11","volume":"50","author":"ER Martins","year":"2012","unstructured":"Martins, E. R. et al. Dominance of serotype Ia among group B streptococci causing invasive infections in nonpregnant adults in Portugal. J. Clin. Microbiol. 50, 1219\u20131227 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"73175_CR44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1099\/jmm.0.052951-0","volume":"62","author":"M Madzivhandila","year":"2013","unstructured":"Madzivhandila, M., Adrian, P. V., Cutland, C. L., Kuwanda, L. & Madhi, S. A. Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa. J. Med. Microbiol. 62, 249\u2013253 (2013).","journal-title":"J. Med. Microbiol."},{"key":"73175_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0098778","volume":"9","author":"G Kwatra","year":"2014","unstructured":"Kwatra, G. et al. Serotype-specific acquisition and loss of group B Streptococcus recto-vaginal colonization in late pregnancy. PLoS One 9, 1\u20139 (2014).","journal-title":"PLoS One"},{"key":"73175_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0169101","volume":"11","author":"Z Dangor","year":"2016","unstructured":"Dangor, Z. et al. Temporal changes in invasive group B Streptococcus serotypes: implications for vaccine development. PLoS One 11, 1\u201312 (2016).","journal-title":"PLoS One"},{"key":"73175_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1371\/journal.pone.0017861","volume":"6","author":"M Madzivhandila","year":"2011","unstructured":"Madzivhandila, M. et al. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLoS One 6, 2\u20137 (2011).","journal-title":"PLoS One"},{"key":"73175_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169101","volume":"11","author":"Z Dangor","year":"2016","unstructured":"Dangor, Z. et al. Temporal changes in invasive group B streptococcus serotypes: Implications for vaccine development. PLoS One 11, e0169101 (2016).","journal-title":"PLoS One"},{"key":"73175_CR49","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.chom.2022.04.007","volume":"30","author":"SN Langel","year":"2022","unstructured":"Langel, S. N., Blasi, M. & Permar, S. R. Maternal immune protection against infectious diseases. Cell Host Microbe 30, 660\u2013674. https:\/\/doi.org\/10.1016\/j.chom.2022.04.007 (2022).","journal-title":"Cell Host Microbe"},{"key":"73175_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96863-x","volume":"11","author":"K Rawal","year":"2021","unstructured":"Rawal, K. et al. Identification of vaccine targets in pathogens and design of a vaccine using computational approaches. Sci. Rep. 11, 17626 (2021).","journal-title":"Sci. Rep."},{"key":"73175_CR51","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","volume":"31","author":"JS Blum","year":"2013","unstructured":"Blum, J. S., Wearsch, P. A. & Cresswell, P. Pathways of antigen processing. Annu. Rev. Immunol. 31, 443\u2013473. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095910 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"73175_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67749-1","volume":"10","author":"T Kar","year":"2020","unstructured":"Kar, T. et al. A candidate multi-epitope vaccine against SARS-CoV-2. Sci. Rep. 10, 10895 (2020).","journal-title":"Sci. Rep."},{"key":"73175_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21176144","volume":"21","author":"FR Shepherd","year":"2020","unstructured":"Shepherd, F. R. & McLaren, J. E. T cell immunity to bacterial pathogens: Mechanisms of immune control and bacterial evasion. Int. J. Mol. Sci. 21, 1\u201332. https:\/\/doi.org\/10.3390\/ijms21176144 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"73175_CR54","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2567.2008.02863.x","volume":"125","author":"C Wagner","year":"2008","unstructured":"Wagner, C. et al. T lymphocytes in acute bacterial infection: Increased prevalence of CD11b+ cells in the peripheral blood and recruitment to the infected site. Immunology 125, 503\u2013509 (2008).","journal-title":"Immunology"},{"key":"73175_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5290604","volume":"2016","author":"D Clarke","year":"2016","unstructured":"Clarke, D. et al. Group B streptococcus induces a robust IFN-\u03b3 response by CD4+ T cells in an in vitro and in vivo model. J. Immunol. Res. 2016, 5290604 (2016).","journal-title":"J. Immunol. Res."},{"key":"73175_CR56","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.4049\/jimmunol.1501014","volume":"196","author":"J Kolter","year":"2016","unstructured":"Kolter, J. et al. Streptococci engage TLR13 on myeloid cells in a site-specific fashion. J. Immunol. 196, 2733\u20132741 (2016).","journal-title":"J. Immunol."},{"key":"73175_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.12213","volume":"142","author":"J Sharon","year":"2014","unstructured":"Sharon, J., Rynkiewicz, M. J., Lu, Z. & Yang, C. Y. Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics. Immunology 142, 1\u201323 (2014).","journal-title":"Immunology"},{"key":"73175_CR58","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.2147\/IJN.S140789","volume":"12","author":"P Ding","year":"2017","unstructured":"Ding, P. et al. Nanoparticle orientationally displayed antigen epitopes improve neutralizing antibody level in a model of porcine circovirus type 2. Int. J. Nanomed. 12, 5239\u20135254 (2017).","journal-title":"Int. J. Nanomed."},{"key":"73175_CR59","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.4049\/jimmunol.174.4.1811","volume":"174","author":"SK Dissanayake","year":"2005","unstructured":"Dissanayake, S. K., Tuera, N. & Ostrand-Rosenberg, S. Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class ii cancer vaccines is independent of transporter associated with Ag processing and the proteasome 1. J. Immunol. 174, 1811\u20131819 (2005).","journal-title":"J. Immunol."},{"key":"73175_CR60","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1080\/22221751.2022.2122585","volume":"11","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Development and evaluation of a multi-epitope subunit vaccine against group B Streptococcus infection. Emerg. Microbes Infect. 11, 2371\u20132382 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"73175_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22646-7","volume":"12","author":"S Rashidi","year":"2022","unstructured":"Rashidi, S. et al. Bioinformatics analysis for the purpose of designing a novel multi-epitope DNA vaccine against Leishmania major. Sci. Rep. 12, 18119 (2022).","journal-title":"Sci. Rep."},{"key":"73175_CR62","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/imm.12780","volume":"152","author":"J Tuju","year":"2017","unstructured":"Tuju, J., Kamuyu, G., Murungi, L. M. & Osier, F. H. A. Vaccine candidate discovery for the next generation of malaria vaccines. Immunology 152, 195\u2013206. https:\/\/doi.org\/10.1111\/imm.12780 (2017).","journal-title":"Immunology"},{"key":"73175_CR63","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1586\/erv.11.114","volume":"10","author":"R Curtiss","year":"2011","unstructured":"Curtiss, R. Vaccine design: innovative approaches and novel strategies. Expert Rev. Vaccines 10, 1385\u20131387 (2011).","journal-title":"Expert Rev. Vaccines"},{"key":"73175_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e01899","volume":"5","author":"S Cheng","year":"2019","unstructured":"Cheng, S. et al. The correlation between expression of sip protein in different serotypes of group B streptococcus and diagnosis. Heliyon 5, e01899 (2019).","journal-title":"Heliyon"},{"key":"73175_CR65","doi-asserted-by":"publisher","first-page":"6813","DOI":"10.1016\/j.vaccine.2021.10.022","volume":"39","author":"Z Dangor","year":"2021","unstructured":"Dangor, Z. et al. Infant serotype specific anti-capsular immunoglobulin G antibody and risk of invasive group B Streptococcal disease. Vaccine 39, 6813\u20136816 (2021).","journal-title":"Vaccine"},{"key":"73175_CR66","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3201\/eid2104.141562","volume":"21","author":"CL Cutland","year":"2015","unstructured":"Cutland, C. L. et al. Increased risk for group b streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004\u20132008. Emerg. Infect. Dis. 21, 638\u2013645 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"73175_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piab042","author":"ST Lukhele","year":"2021","unstructured":"Lukhele, S. T. et al. Investigation of possible nosocomial-associated invasive group B streptococcus disease using whole-genome sequencing: a report of 3 cases. J. Pediatr. Infect. Dis. Soc.https:\/\/doi.org\/10.1093\/jpids\/piab042 (2021).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"73175_CR68","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12879-020-05603-5","volume":"21","author":"FJ Bobadilla","year":"2021","unstructured":"Bobadilla, F. J., Novosak, M. G., Cortese, I. J., Delgado, O. D. & Laczeski, M. E. Prevalence, serotypes and virulence genes of Streptococcusagalactiae isolated from pregnant women with 35\u201337 weeks of gestation. BMC Infect. Dis. 21, 73 (2021).","journal-title":"BMC Infect. Dis."},{"key":"73175_CR69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1172\/JCI200316270","volume":"111","author":"TO Harris","year":"2003","unstructured":"Harris, T. O., Shelver, D. W., Bohnsack, J. F. & Rubens, C. E. A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J. Clin. Investig. 111, 61\u201370 (2003).","journal-title":"J. Clin. Investig."},{"key":"73175_CR70","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1086\/595564","volume":"199","author":"I Margarit","year":"2009","unstructured":"Margarit, I. et al. Preventing bacterial infections with pilus-based vaccines: The group B streptococcus paradigm. J. Infect. Dis. 199, 108\u2013115 (2009).","journal-title":"J. Infect. Dis."},{"key":"73175_CR71","first-page":"1029","volume":"152","author":"KN Seifert","year":"2006","unstructured":"Seifert, K. N. et al. A unique serine-rich repeat protein (Srr-2) and novel surface antigen (\u03b5) associated with a virulent lineage of serotype III Streptococcusagalactiae. Microbiology (N Y) 152, 1029\u20131040 (2006).","journal-title":"Microbiology (N Y)"},{"key":"73175_CR72","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: Improvements in performance and usability article fast track. Mol. Biol. Evol. 30, 772\u2013780 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"73175_CR73","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1093\/bioinformatics\/btu531","volume":"30","author":"A Larsson","year":"2014","unstructured":"Larsson, A. Aliview: a fast and lightweight alignment viewer and editor for large data sets. Bioinformatics 30, 3276\u20133278 (2014).","journal-title":"Bioinformatics"},{"key":"73175_CR74","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","volume":"25","author":"AM Waterhouse","year":"2009","unstructured":"Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M. & Barton, G. J. Jalview Version 2\u2014A multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189\u20131191 (2009).","journal-title":"Bioinformatics"},{"key":"73175_CR75","first-page":"1","volume":"7","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 7, 1\u20137 (2007).","journal-title":"BMC Bioinform."},{"key":"73175_CR76","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/bioinformatics\/btq249","volume":"26","author":"NY Yu","year":"2010","unstructured":"Yu, N. Y. et al. PSORTb 3.0: Improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26, 1608\u20131615 (2010).","journal-title":"Bioinformatics"},{"key":"73175_CR77","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov, I., Bangov, I., Flower, D. R. & Doytchinova, I. AllerTOP vol 2\u2014A server for in silico prediction of allergens. J. Mol. Model. 20, 2278 (2014).","journal-title":"J. Mol. Model."},{"key":"73175_CR78","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen, M. C., Peters, B., Nielsen, M. & Marcatili, P. BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 45, W24\u2013W29 (2017).","journal-title":"Nucleic Acids Res."},{"key":"73175_CR79","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/prot.25674","volume":"87","author":"MS Klausen","year":"2019","unstructured":"Klausen, M. S. et al. NetSurfP-20: Improved prediction of protein structural features by integrated deep learning. Proteins Struct. Funct. Bioinform. 87, 520\u2013527 (2019).","journal-title":"Proteins Struct. Funct. Bioinform."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73175-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73175-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73175-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T16:58:44Z","timestamp":1732813124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73175-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73175"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73175-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Human Research Ethics Committee of the University of the Witwatersrand (HREC140203\/M170740).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"22665"}}